Fig. 4From: Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcomaConfirmation of immune risk score model. a Kaplan–Meier survival curves of overall survival between high-risk and low-risk patients. b ROC curve AUC statistics assess the predictive power of the immune risk score modelBack to article page